Why BioXcel Therapeutics Stock Is Sinking Today
The company’s chief commercial officer resigned.
The company’s chief commercial officer resigned.
Customers’ credit scores for the “buy now, pay later” specialist are starting to slip as well.
The streaming leader has been ignoring mergers and acquisitions for too long.
Several analysts raised their price targets on the stock, at times, significantly.
FRC earnings call for the period ending September 30, 2021.
PNFP earnings call for the period ending September 30, 2021.
JPM earnings call for the period ending September 30, 2021.
Lower interest rates and some product updates at a conference seemed to give the stock a boost.
The gold stock will likely upgrade its 2021 guidance later this month.
This was supposed to be a strong year for new car sales and satellite radio listening.